Introduction
POMGnT1 is the glycosyltransferase that catalyzes the transfer of N-acetylglucosamine (GlcNAc) to O-mannose of glycoproteins, the second step of Ser/Thr O-mannosylation (Yoshida et al., 2001 ; reviewed in Endo and Toda, 2003) . Mutations in the POMGnT1 gene cause muscleeye-brain (MEB) disease, a rare autosomal recessive disorder characterized by congenital muscular dystrophy with elevated serum creatine kinase (CK) levels, severe visual failure, and gross mental retardation (Yoshida et al., 2001 ).
0925-4773/$ -see front matter Ó 2008 Elsevier Ireland Ltd. All rights reserved. doi:10.1016/j.mod.2008.12.001 a-Dystroglycan (a-DG) is a heavily glycosylated glycoprotein and a well-known substrate of POMGnT1. Dystroglycan is encoded by a single gene (DAG1) and is cleaved into two proteins, a-dystroglycan (a-DG) and b-dystroglycan (b-DG), by posttranslational processing (Ibraghimov-Beskrovnaya et al., 1992) . DGs are central components of the dystrophinglycoprotein complex (DGC) at the sarcolemma, and a-DG was shown to serve as a cell surface receptor for laminin (Ibraghimov-Beskrovnaya et al., 1992) , agrin (Gee et al., 1994; Campanelli et al., 1994) , perlecan (Peng et al., 1998; Kanagawa et al., 2005) , and neurexin (Sugita et al., 2001 ). In skeletal muscle, the laminin-a-DG linkage is thought to be critical for plasma membrane stability (recently reviewed in Kanagawa and Toda 2006) . In MEB muscle, the a-DG core protein is preserved but hypo-glycosylated, and a-DG prepared from the muscle fails to bind laminin in vitro . Therefore, it is proposed that the disruption of the a-DG-laminin linkage is the main pathomechanism of dystrophic changes seen in MEB muscle.
To further elucidate the molecular pathogenesis of MEB disease, we generated POMGnT1-knockout mice using a gene targeting technique, and examined the mutant skeletal muscle. During our experiments, Liu et al. reported the generation of POMGnT1-deficient mice (Liu et al., 2006) . The report showed severe muscle pathology, but the mechanism by which POMGnT1 deficiency causes muscle phenotype was not clearly shown. In this report, we report that POMGnT1-deficient mice show remarkably minimal signs of muscle degeneration and regeneration, but also show small muscle mass, reduced numbers of muscle fibers, and impaired muscle regeneration. POMGnT1-deficient myoblasts proliferate poorly in vitro. The proliferation was not improved by retrovirus vector-mediated POMGnT1 expression in POMGnT1 À/À myoblasts, suggesting that a-DG-laminin interaction in vivo is important for maintenance of the proliferative activity of satellite cells.
Results

Inactivation of the POMGnT1 gene in mice
We mutated the POMGnT1 gene by replacing exon 18 with a neomycin-resistance gene in mouse ES cells (depicted in Fig. 1 ). Two ES clones successfully entered the germline. Although there was no evidence of embryonic lethality, more than 60% of the homozygotes died within 3 weeks of birth. Survivors were smaller than their wild-type littermates (Fig. 3A) throughout life, but most of them had a normal life span. We confirmed that the POMGnT1 À/À mice completely lacked the POMGnT1 enzyme activity ( Fig. 2A) . A monoclonal antibody, VIA4-1, that reacts with the suger moiety of a-DG gave no signal in either POMGnT1 À/À brain (Fig. 2B) Fig. 1 ). Electron microscopy also showed that the sarcomere structures are almost normal in POMGnT1 À/À mice.
We next examined the serum creatine kinase (CK) levels, an index of on-going muscle damage, in wild-type, POMGnT1
À/ À , and age-matched mdx mice (Fig. 5) . The serum CK levels of 5-to 20-week-old POMGnT1 À/À mice were slightly higher (av. 586 U/L, n = 10) (p < 0.05) than those of wild-type littermates (less than 100 U/L, n = 4), but were much lower than those of mdx mice (more than 5000 U/L, n = 3, p < 0.01). The serum CK levels of 2-year-old POMGnT1 À/À mice were still low (less than 300 U/L, n = 4).
2.3.
Repetitive muscle injury causes more fibrosis and fatty infiltration in POMGnT1 À/À than in WT TA muscle
Dystroglycans expressed on the cell membrane of satellite cells are proposed to play an important role in muscle regeneration . In addition, the average size of POMGnT1 À/À myofibers was smaller than those of wild-type myofibers (Fig. 4) . Moreover, the number of myofibers is reduced in POMGnT1 À/À skeletal muscle of neonatal and adult POMGnT1 mice, suggesting proliferation defect of POMGnT1 À/À myoblasts (Fig. 4) mice (Fig. 7) . Three days after plating of single myofibers on Matrigel-coated 24-well plates in growth medium, the numbers of detached satellite cells (activated and proliferating satellite cells) were counted. In both extensor digitorum longus (EDL) (fast twitch muscle) and soleus (slow twitch muscle) muscles, the numbers of activated satellite cells and proliferating satellite cells (myoblasts) around the parental myofiber were more numerous in wild-type than in POMGnT1
À/À (Fig. 7) . Furthermore, wild-type satellite cells migrate a little faster than POMGnT1 À/À satellite cells on transwells (data not shown), although the difference was little. Therefore, our results suggest that POMGnT1 À/À satellite cells are activated more slowly or proliferate more slowly than wild-type. We next isolated satellite cells from hind limb muscles of wild-type and POMGnT1 À/À mice by a monoclonal antibody, SM/C-2.6, and flow cytometry (Fukada et al., 2007) , and examined their proliferation rate. The total yield of satellite cells per gram of POMGnT1 À/À muscle tissue was nearly the same as those of wild-type muscle (data not shown). The percentage of Ki67-positive satellite cells (cycling cells) was less than 1% in both wild-type and POMGnT1 À/À mice, indicating that they are in the quiescent stage (data not shown). However, after plating wild-type and POMGnT1 À/À satellite cells onto Matrigel-coated 6-well plates at the same density, we found that POMGnT1 À/À satellite cells grew poorly in growth medium (Fig. 7B ). The timing of activation (i.e. enlargement of the cytoplasm and MyoD expression) was the same with that of wild-type satellite cells (data not shown). Next, we cultured satellite cells on Matrigel-coated 24-well-plates in growth medium, and the cells growth was evaluated by MTT assay 1, 2, 3, 4, 5, 6, and 7 days after plating (Fig. 8) . The assay revealed that wild-type myoblasts proliferated more rapidly than POMGnT1 À/À myoblasts in vitro. POMGnT1 À/À myoblasts fused normally to form multinucleated myotubes in differentiation conditions like the wild-type (data not shown), and there was no significant difference in the fusion index between wild-type (45%) and POMGnT1 À/À myoblasts (40%) (p > 0.05). , and mdx mice.
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Next, we examined whether restoration of the expression of the POMGnT1 gene in mutant myoblasts improved their proliferation. To this end, we prepared a retrovirus vector, (pMX-POMGnT1-IRES-GFP) expressing human POMGnT1 and GFP. The recombinant retrovirus successfully restored O-mannosyl glycosylation of a-DG (Fig. 7A ), but the proliferation rate was not changed (Fig. 8B) .
2.5.
Cell growth signaling in POMGnT1 À/À myoblasts It was previously reported that enhanced expression of a7b1 integrin ameliorates the development of muscular dystrophy and extends longevity in a7BX2-mdx/utr( À/À ) transgenic mice (Burkin et al., 2001; Burkin et al., 2005) , suggesting that integrin compensates for the function of a-DG in skeletal muscle to some extent. Therefore, we next examined the expression of b1-integrin in wild-type and POMGnT1 À/À myoblasts ( Supplementary Fig. 1 ). Western blotting, however, showed no difference between the b1-integrin protein levels in wild-type and POMGnT1 À/À myoblasts ( Supplementary   Fig. 1A) . Furthermore, FACS analysis showed similar levels of b1 integrin expression on the surfaces of myoblasts ( Supplementary Fig. 1B ). We then examined the activation levels of Akt and GSK-3b, both of which are involved in the , wild-type, and mdx mice. Serum CK levels of 7-20 weeks old POMGnT1 À/À mice (5 males and 5 females), wild-type littermates (3 males and 1 female), and three male mdx mice were measured and plotted on the graph with average. * p < 0.05.
regulation of cell survival and proliferation. The levels of phosphorylation of these two kinases in POMGnT1 À/À myoblasts were similar with those in wild-type myoblasts ( Supplementary Fig. 1C ). Consistent with these observations, TUNEL assay indicated that apoptosis is rare both in POMGnT1 À/À and wild-type muscles (data not shown).
Discussion
In this study, we showed that in spite of mild muscle degeneration, the POMGnT1 À/À satellite cells have much lower proliferative activity than wild-type satellite cells. The defect was not recovered by restoration of normal glycosylation of a-DG in mutant satellite cells. Together with the reduced sizes and the reduced numbers of myofibers of neonatal and adult POMGnT1 À/À mice, these observations suggest that deficiency of POMGnT1 enzymatic activity impairs the functions of satellite cells.
Two mouse models of muscle-eye-brain (MEB) disease
Our POMGnT1 À/À mice are the second mouse model of MEB disease. The first one was generated by gene trapping with a retroviral vector inserted into the second exon of the mouse POMGnT1 locus (Liu et al., 2006). As described in the literature, the phenotype is similar to ours with some differences. Our model shows much milder muscle phenotypes than the previously reported model, but also shows much a lower survival rate in the postnatal stage than the first model does. This would be due to more severe developmental abnormalities of the central nervous system of our mouse model, including disruption of the glia limitans, abnormal migration of neurons, and reactive gliosis in the cerebral cortex (manuscript in preparation), although these are also observed in the first model Hu et al., 2007) . Mutation of the POMGnT1 gene is the cause of muscle-eyebrain disease (MEB) (Yoshida et al., 2001) , which is characterized by severe congenital muscular dystrophy (Voit and Tome, 2004) . Although glycosylation of a-DG was completely perturbed in our model, the POMGnT1 À/À muscle showed only marginal pathological changes. Furthermore, POMGnT1
À/À muscle showed normally formed muscle basal lamina on EM. These observations are in sharp contrast to the condition in humans. One possibility is that in the mouse, molecules other than a-DG are involved in the linkage of the sarcolemma with the extracellular matrix proteins, stabilizing the plasma membrane. As a candidate molecule, we examined b1-integrin expression in POMGnT1 À/À muscle, but found that the level was not up-regulated. Therefore, the mechanism that explains this discrepancy remains to be clarified in a future study. 
3.2.
Null mutation in POMGnT1 reduces proliferative activity of muscle satellite cells
POMGnT1
À/À myoblasts proliferate poorly in vitro. This observation suggested that the proliferation of myoblasts is stimulated by growth signals via laminin-a-DG interaction.
However, retrovirus vector-mediated gene transfer of the POMGnT1 gene, which successfully restored O-mannosyl glycosylation of a-DG, did not restore the proliferation activity of the POMGnT1 À/À myoblasts. DMD myoblasts proliferate poorly and quickly reach senescence. The impaired proliferation activity has been ascribed to repeated activation of satellite cells due to repetitive cycles of muscle degeneration and regeneration (Blau et al., 1983) . In contrast, POMGnT1
À/À muscle lacks signs of active regeneration. Therefore, the reduced proliferation activity of POMGnT1 À/À mouse myoblasts is not likely due to excessive cell division of satellite cells. Rather, it is likely that a-DG-laminin interaction in the niche, i.e. beneath the basal lamina of skeletal muscle myofibers, is important for maintenance of proliferative activity of satellite cells. However, the possibility that POMGnT1-deficiency causes aberrant glycosylation of molecules other than a-DG should be also tested.
Our results also suggested that the lack of a-DG-laminin interaction resulted in reduced numbers of muscle fibers (hypoplasia). Importantly, we found that myofibers of older POMGnT1 À/À mice tend to be hypertrophied ( Supplementary   Fig. 2 ). POMGnT1 À/À muscle might compensate the muscle power by hypertrophy of the myofibers. This is consistent with our observation that POMGnT1 À/À muscle increases its mass in an overload model (unpublished data). Importantly, recent studies suggest that this process is satellite cell-independent (Sandri M., 2008) . Recently, Liu et al. showed that over-expression of integrin a7b1 in C2C12 myoblasts promoted proliferation of the cells (Liu et al., 2008) . Importantly, however, we did not observe up-regulation of integrin a7b1 expression in POMGnT1 À/À satellite cells. These observations suggest that dystroglycans and integrins have distinct roles in the regulation of muscle satellite cells. In summary, we generated POMGnT1-null mice. The mice showed low serum creatine kinase levels and minimal signs of muscle degeneration and regeneration. Nonetheless, POMGnT1 À/À muscle showed the reduction in the size and the number of myofibers. Furthermore, repeated injection of cardiotoxin showed impaired muscle regeneration in POMGnT1 À/ À mice. POMGnT1 À/À myoblasts proliferated poorly in vitro.
Over-expression of protein restored glycosylation of a-DG, but did not improve the proliferation of POMGnT1 À/À myoblasts at all. Collectively, our results suggest that POMGnT1 enzymatic activity is important for maintenance of the proliferative activity of satellite cells in vivo.
Experimental procedures
The targeting strategy in ES cells is depicted in Fig. 1 . Genomic DNA (8.6 kb) covering almost the entire POMGnT1 gene was isolated from 129/SvJ mice by using two specific primers: m1F2 primer, 5 0 -gat tcc tga agt cat gga ctg gc-3 0 and m1B5, 5 0 -tct aaa ggt ctc tgt gtg agt ctg tca g-3 0 . The PCR product was then cloned into a TOPO TA cloning vector (Invitrogen, Carlsbad, CA) and sequenced (AB053221). To construct the targeting vector, a 630-bp RsrII-Hind III fragment, containing exon18 was replaced with a neo expression cassette (Stratagene) (Fig. 1) . Electroporation and screening of ES cells (129Svev origin) were performed by Ingenious Targeting Laboratory, Inc. (Stony Brook, NY). Homologous recombination in ES cells was confirmed by Southern blotting. Two independent positive ES clones were injected into C57BL/6 blastocysts, which gave rise to offspring carrying the mutated allele. Genotyping of the mice was done by PCR. One primer set is designed to amplify exon 18: F2, 5 0 -cag cag ttt cct tcc ttc taa ccc-3 0 and B4, 5 0 -att tgg tct ggt ccc ttg gct c-3 0 (278 bp). Neo primers were used to amplify the neo resistance gene, and thereby detect the mutant allele: neo-F, 5 0 -agg cta ttc ggc tat gac tgg g-3 0 , and neo-R, 5 0 -tac ttt ctc ggc agg agc aag gtg-3 0 (288 bp). Dystrophin-deficient mdx mice of C57BL/6 genetic background were provided by T. Sasaoka at the National Institute for Basic Biology, Japan. The Experimental Animal Care and Use Committee of the National Institute of Neuroscience approved all experimental protocols.
POMGnT1 enzymatic activity
Brains were obtained from 8-week-old mice and homogenized with nine volumes (weight/volume) of 10 mM TrisHCl, pH 7.4, 1 mM EDTA, and 250 mM sucrose. After centrifugation at 900g for 10 min, the supernatant was subjected to ultracentrifugation at 100,000g for 1 h. The precipitates were used as the microsomal membrane fraction. The protein concentration was determined by BCA assay (Pierce, Rockford, IL). The enzymatic activity assay measured the amount of [ PerkinElmer, Inc., Wellesley, MA), 2 mM mannosyl peptide (Ac-Ala-Ala-Pro-Thr-(Man)-Pro-Val-Ala-Ala-Pro-NH 2 ), 10 mM MnCl 2 , 2% Triton X-100, 5 mM AMP, 200 mM GlcNAc, 10% glycerol, and 100 lg of microsomal membrane fraction was incubated at 37°C for 1 h. After boiling for 3 min, the mixture was analyzed by reverse phase HPLC using a Wakopak 5C18-200 column (4.6 · 250 mm, Wako Pure Chemical Industries, Osaka, Japan). The gradient solvents were aqueous 0.1% trifluoroacetic acid (solvent A) and acetonitrile containing 0.1% trifluoroacetic acid (solvent B). The mobile phase consisted of 100% A for 10 min and then a linear gradient to 75% A:25% B over 25 min. Peptide separation was monitored at 214 nm, and the radioactivity of each fraction (1 ml) was measured using a liquid scintillation counter.
Antibodies
All antibodies used in Western blotting, immunohistochemistry, and FACS are listed in Supplementary Table 1.
Histology and immunohistochemical analysis
Muscle cryosections (6-10 lm) were stained with hematoxylin and eosin (H&E), or treated with 0.1% Triton X-100, blocked with 5% goat serum/1% BSA in PBS, then incubated with primary antibodies (Supplementary Table 1 ) at 4°C overnight. After washing with PBS, specimens were incubated with a secondary antibody labeled with Alexa Fluor 488 or Alexa Fluor 568 (1:200-400 dilution; Molecular Probes) at RT for 1 h, counterstained with TOTO-3 (1:5000; Molecular Probes), and then mounted in Vectashield (Vector). The images were recorded using a confocal laser scanning microscope system TCSSP TM (Leica). For fiber size measurement, cross-sections of muscle were stained with anti-laminin a2
antibody and recorded and quantified by a digital microscope, BIOREVO (http://www.biorevo.jp; KEYENCE, Osaka, Japan).
Western blotting
Western blotting was performed as previously described (Hosaka et al., 2002) . In brief, 20 lg of muscle proteins were separated on 7.5% SDS-PAGE gels and transferred to a PVDF membrane (Millipore, Bedford, MA). After incubation with primary antibodies (Supplementary Table 1) , the membranes were incubated in HRP-labeled secondary antibodies (1:5000 dilution) (Amersham Biosciences, UK). The signals were detected by using an ECL plus Western Blotting Detection System (GE Healthcare, Buckinghamshire, UK).
4.6.
Laminin blot overlay assay
An overlay assay was performed as described by Moore et al. (2002) . In brief, WGA-enriched homogenates were prepared from wild-type and POMGnT1 À/À brains, separated on SDS-PAGE gels, blotted onto a PDVF membrane, and incubated with mouse EHS laminin (Trevigen, Gaithersburg, MD, USA). Bound laminin was probed with anti-laminin antibody (Sigma, St. Louis, MO) and ECL system (GE Healthcare, Buckinghamshire, UK).
Single fiber preparation and culture
Single fibers were prepared from extensor digitorum longus (EDL) and soleus muscles of wild-type and POMGnT1 À/À mice as described by Rosenblatt et al. (1995) . Each fiber was plated onto Matrigel (BD Biosciences, Bedford, MA)-coated 24-well plates and cultured in growth medium for 3 days. Then, the number of cells around the parental fiber was counted.
4.8.
Isolation of satellite cells, proliferation assay, and fusion index Satellite cells were prepared from wild-type and POMGnT1 À/À mice by FACS as previously described (Fukada et al., 2007) . Sorted cells were plated on Matrigel-coated 24-well-plates at a density of 1 · 10 4 cells/well in a growth medium, DMEM (High glucose; Wako, Osaka), supplemented with 20% fetal bovine serum (Equitech-bio, Inc., Kerville, TX), human recombinant bFGF (2.5 ng/ml) (Invitrogen), recombinant mouse HGF (25 ng/ml) (R&D Systems, Minneapolis, MN), and heparin (5 lg/ml) (Sigma). For the MTT assay, 100 ll of 0.5% MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (Dojindo, Kumamoto, Japan) was added to the culture at each time point, and after 4 h incubation, the cells were collected in 1 ml of acid isopropanol solution. OD 590 was measured and plotted. After reaching 70% confluency, the cells were induced to differentiate into myotubes by low-serum medium (5% horse serum/DMEM), and 18 h later, the cells were fixed, stained with anti-sarcomeric a-actinin antibody and DAPI (nuclei). Fusion index was calculated as (the numbers of nuclei in the myotubes/total nuclei) · 100%.
Production of retrovirus vectors
pMXs-IG (Kitamura et al., 2003) was kindly provided by T.Kitamura at Tokyo University. Human POMGnT1 cDNA, which has an Xpress epitope and a His-tag at the N-terminal (Akasaka-Manya et al., 2004) , was cloned into the multi-cloning site upstream of IRES-GFP of the vector. Vector particles were produced by transfection of the vector plasmid into PLAT-E packaging cells (Kitamura et al., 2003) . Proliferating satellite cells (myoblasts) were incubated with the viral vectors overnight and 4 days later, successfully transduced GFPpositive cells were collected by FACS, and the proliferation rate was evaluated by MTT assay.
Electron microscopy
Mice were perfused transcardially with a solution of 2% paraformaldehyde and 2.5% glutaraldehyde in PBS under deep pentobarbital anesthesia. The anterior tibial muscles were excised, embedded in 3% agarose, and sections (70 lm in thickness) were prepared on a Vibratome. Sections were fixed in OsO 4 , ehydrated, and embedded in Cartepoxy resin. Ultrathin sections were prepared, stained with lead citrate and uranyl acetate, and observed under a Hitachi H-7000 transmission electron microscope.
Measurement of serum creatine kinase (CK)
Blood samples were obtained from the tail vein or directly from the heart at sacrifice. Serum CK level was measured by colorimetric assay using an FDC3500 clinical biochemistry autoanalyzer (FujiFilm Medical Co., Tokyo, Japan).
Cardiotoxin (CTX) injection
To induce muscle regeneration, CTX (10 lmol/L in saline; Sigma, St. Louis, MO) was injected into the tibialis anterior (TA) muscles three times at indicated intervals. The muscle cross-sections were stained with Oil red O (Muto Pure Chemicals Co., Ltd., Tokyo, Japan) to detect lipid droplets, or with Sirius red F3B (Sigma Chemical Co., St. Louis, MO) in saturated picric acid to stain collagen fibers.
